Telehealth-Aided Outpatient Management of Acute Heart Failure in a Specialist Virtual Ward Compared with Standard Care
Telehealth-gestützte ambulante Behandlung der akuten Herzinsuffizienz in einer spezialisierten virtuellen Station im Vergleich zur Standardversorgung
ESC Heart Failure · 01.12.2024 · 11 (6) · 4172-4184
DOI: 10.1002/ehf2.15003 ↗Auf einen Blick
Eine propensity score gematchte Kohortenstudie fand unter telehealth-gestützter ambulanter Behandlung bei akuter Herzinsuffizienz weniger Wiederaufnahmen und eine niedrigere Mortalität als unter Standardversorgung.
Fragestellung
Wie sind Wiederaufnahmen und Mortalität bei telehealth-gestützter ambulanter Behandlung der akuten Herzinsuffizienz in einer spezialisierten virtuellen Station im Vergleich zur Standardversorgung?
Methode
Kohortenstudie mit Propensity-Score-Matching; Vergleich mit Standardversorgung; Beobachtungszeitraum Mai 2022 bis Oktober 2023, Nachbeobachtung 1, 3, 6 und 12 Monate.
Ergebnisse
Nach Matching waren Wiederaufnahmen und Mortalität in der HFVW in allen Zeitpunkten niedriger. Für Wiederaufnahmen lagen die OR bei 0,3, 0,15, 0,35 und 0,25; für Mortalität bei 0,26, 0,11, 0,35 und 0,6.
Schlussfolgerung der Autor:innen
Die telehealth-gestützte Betreuung in einer spezialisierten virtuellen Station kann bei geeigneten Patient:innen eine sichere und wirksame Alternative zur Hospitalisierung sein.
Kernaussagen
- Weniger Wiederaufnahmen unter HFVW als unter Standardversorgung
- Niedrigere Mortalität unter HFVW in allen Zeitpunkten
- Tägliche Schrittzahl war mit kurzfristigen Outcomes assoziiert
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Vergleichsstudie in der Zeitschrift ESC Heart Failure, online erschienen am 13.08.2024. Verfasst von Rajiv Sankaranarayanan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Liverpool University Hospitals NHS Foundation Trust, Aintree Hospital, Liverpool, UK. Hauptthemen laut MEDLINE: Heart Failure, Telemedicine. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHS Transformation Directorate (NHSX).
Abstract (Originalsprache)
Aims
The aim of this propensity score matched cohort study was to assess the outcomes of telehealth-guided outpatient management of acute heart failure (HF) in our virtual ward (HFVW) compared with hospitalized acute HF patients. Methods and results This cohort study (May 2022–October 2023) assessed outcomes of telehealth-guided outpatient acute HF management using bolus intravenous furosemide in a HF-specialist VW. Propensity score matching (PSM) was performed using logistic regression to adjust for potential differences in baseline patient characteristics between HFVW and standard care [Get With The Guidelines-HF score, clinical frailty score (CFS), Charlson co-morbidity index (CCI), NT-proBNP, and ejection fraction]. Clinical outcomes (re-hospitalizations and mortality) were compared at 1, 3, 6, and 12 months versus standard care-SC (acute HF patients managed without telehealth in 2021). Five hundred fifty-four HFVW ADHF patients (age 73.1 ± 10.9 years; 46% female) were compared with 404 ADHF patients (74.2 ± 11.8; P = 0.15 and 49% female) in the standard care-SC cohort. After propensity score matching for baseline patient characteristics, re-hospitalizations were significantly lower in the HFVW compared with SC (1 month-HFVW 8.6% vs. SC-21.5%, P < 0.001; 3 months-21% vs. 30%, P = 0.003; 6 months-28% vs 41%, P < 0.001 and 12 months-47% vs. 57%, P = 0.005) and mortality was also lower at 1 month (5% vs. 13.7%; P < 0.001), 3 months (9.5% vs. 15%; P = 0.001), 6 months (15% vs. 21%; P = 0.03), and 12 months (20% vs. 26%; P = 0.04). Multivariate logistic regression analysis showed that compared with standard care, HFVW management was associated with lower odds of readmission (1-month odds ratio (OR) = 0.3 [95% Confidence Interval CI 0.2–0.5], P < 0.0001; 3 month OR = 0.15 [0.1–0.3], P < 0.0001; 6-month OR = 0.35 [0.2–0.6], P = 0.0002; 12-month OR = 0.25 [0.15–0.4], P ≤ 0.001 and mortality (1-month OR = 0.26 [0.14–0.48], P < 0.0001; 3-month OR = 0.11 [0.04–0.27], P < 0.0001; 6-month OR = 0.35, [0.2; 0.61], P = 0.0002; 12-month OR = 0.6 [0.48; 0.73], P = 0.03. Higher GWTG-HF score independently predicted increased odds of re-hospitalization (1-month OR = 1.2 [1.1–1.3], P < 0.001; 3-month OR = 1.5 [1.37; 1.64], P < 0.0001; 6-month OR = 1.3 [1.2–1.4], P < 0.0001; 12-month OR = 1.1 [1.05–1.2], P = 0.03) as well as mortality (1-month OR = 1.21 [1.1–1.3], P < 0.0001; 3-month OR = 1.3 [1.2–1.4], P < 0.0001; 6-month OR = 1.2 [1.1–1.3], P < 0.0001; 12-month OR = 1.3 [1.1–1.7], P = 0.02). Similarly higher CFS also independently predicted increased odds of re-hospitalizations (1-month OR = 1.9 [1.5–2.4], P < 0.0001; 3-month OR = 1.8 [1.3–2.4], P = 0.0003; 6-month OR = 1.4 [1.1–1.8], P = 0.015; 12-month OR 1.9 [1.2–3], P = 0.01]) and mortality (1-month OR = 2.1 [1.6–2.8], P < 0.0001; 3-month OR = 1.8 [1.2–2.6], P = 0.006; 6-month OR = 2.34 [1.51–5.6], P = 0.0001; 12-month OR = 2.6 [1.6–7], P = 0.02). Increased daily step count while on HFVW independently predicted reduced odds of re-hospitalizations (1-month OR = 0.85[0.7–0.9], P = 0.005), 3-month OR = 0.95 [0.93–0.98], P = 0.003 and 1-month mortality (OR = 0.85 [0.7–0.95], P = 0.01), whereas CCI predicted adverse 12-month outcomes (OR = 1.2 [1.1–1.4], P = 0.03).
Conclusions
Telehealth-guided specialist HFVW management for ADHF may offer a safe and efficacious alternative to hospitalization in suitable patients. Daily step count in HFVW can help predict risk of short-term adverse clinical outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Liverpool University Hospitals NHS Foundation Trust, Aintree Hospital, Liverpool, UK.
- Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, UK.
- GIRFT (Getting It Right First Time), NHS England, London, UK.
- North West Coast Cardiac Clinical Network, NHS England, London, UK.
- Mersey Care NHS Foundation Trust, Liverpool, UK.
- Health Technology and Access Services, Community Services Division, Mersey Care NHS Foundation Trust, Liverpool, UK.
ORCID-Profile: Rajiv Sankaranarayanan, Debar Rasoul, Gregory Y H Lip
Förderung
- NHS Transformation Directorate (NHSX)
Zitieren
APA
Sankaranarayanan, R., Rasoul, D., Murphy, N., Kelly, A., Nyjo, S., Jackson, C., O'Connor, J., Almond, P., Jose, N., West, J., Kaur, R., Oguguo, C., Douglas, H., & Lip, G. Y. H. (2024). Telehealth-Aided Outpatient Management of Acute Heart Failure in a Specialist Virtual Ward Compared with Standard Care. ESC Heart Failure, 11(6), 4172-4184. https://doi.org/10.1002/ehf2.15003
Vancouver
Sankaranarayanan R, Rasoul D, Murphy N, Kelly A, Nyjo S, Jackson C, et al. Telehealth-Aided Outpatient Management of Acute Heart Failure in a Specialist Virtual Ward Compared with Standard Care. ESC Heart Failure. 2024;11(6):4172-4184. doi:10.1002/ehf2.15003
BibTeX
@article{Sankaranarayanan2024,
author = {Sankaranarayanan, Rajiv and Rasoul, Debar and Murphy, Naomi and Kelly, AnneMarie and Nyjo, Siji and Jackson, Carolyn and O'Connor, Jane and Almond, Peter and Jose, Nisha and West, Jenni and Kaur, Rosie and Oguguo, Chukwemeka and Douglas, Homeyra and Lip, Gregory Y H},
title = {Telehealth-Aided Outpatient Management of Acute Heart Failure in a Specialist Virtual Ward Compared with Standard Care},
journal = {ESC Heart Failure},
year = {2024},
volume = {11},
number = {6},
pages = {4172--4184},
doi = {10.1002/ehf2.15003}
}
EUVIMED